$3.46 Billion is the total value of INVESTOR AB's 8 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NDAQ | NASDAQ Inc | $3,456,036,000 | -15.1% | 19,394,142 | 0.0% | 99.83% | -0.0% | |
| WeWork Inccl a | $1,549,000 | -20.7% | 227,139 | 0.0% | 0.04% | -6.2% | ||
| C | Citigroup Inc | $1,335,000 | -11.6% | 25,000 | 0.0% | 0.04% | +5.4% | |
| IAS | New | Integral Ad Science Hldng Co | $1,204,000 | – | 87,228 | +100.0% | 0.04% | – |
| AGRX | Agile Therapeutics Inc. | $737,000 | -57.2% | 3,510,189 | 0.0% | 0.02% | -50.0% | |
| LAZ | Lazard Ltd | $443,000 | -24.8% | 12,850 | 0.0% | 0.01% | -7.1% | |
| SWK | Stanley Black & Decker Inc | $433,000 | -20.3% | 3,100 | 0.0% | 0.01% | 0.0% | |
| Babylon Holdings Ltd | $97,000 | -33.6% | 25,000 | 0.0% | 0.00% | -25.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NASDAQ OMX GROUP INC | 42 | Q3 2023 | 100.0% |
| AGILE THERAPEUTICS INC | 32 | Q1 2022 | 3.5% |
| CHINACACHE INTL HLDG LTD | 21 | Q2 2018 | 7.3% |
| MATTERSIGHT CORP | 21 | Q2 2018 | 2.0% |
| CORCEPT THERAPEUTICS INC | 18 | Q3 2017 | 1.8% |
| TANGOE INC | 16 | Q1 2017 | 4.0% |
| NEURONETICS INC | 11 | Q4 2020 | 3.3% |
| CONSTANT CONTACT INC | 11 | Q4 2015 | 0.7% |
| CARLYLE GROUP LP | 11 | Q1 2018 | 0.2% |
| STANLEY BLACK & DECKER, INC. | 9 | Q3 2023 | 0.0% |
View INVESTOR AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ABB LTD | June 27, 2022 | 265,385,142 | 14.0% |
| ChinaCache International Holdings Ltd.Sold out | February 14, 2019 | 0 | 0.0% |
| AGILE THERAPEUTICS INC | February 17, 2015 | 3,510,189 | 18.9% |
| GREENWAY MEDICAL TECHNOLOGIES INCSold out | February 14, 2014 | 0 | 0.0% |
| TANGOE INC | February 14, 2014 | 1,440,000 | 3.8% |
| Mattersight CorpSold out | May 10, 2012 | 0 | 0.0% |
| ISTA PHARMACEUTICALS INC | February 14, 2011 | 1,258,075 | 3.8% |
| ACHILLION PHARMACEUTICALS INC | February 11, 2011 | 1,980,129 | 3.4% |
| ChinaCache International Holdings Ltd. | February 11, 2011 | 55,885,475 | 14.5% |
| ISTA PHARMACEUTICALS INC | April 08, 2005 | 2,001,896 | 7.8% |
View INVESTOR AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-11-06 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2022-12-16 |
| 13F-HR | 2022-11-14 |
| SC 13D/A | 2022-08-26 |
| 13F-HR | 2022-08-15 |
View INVESTOR AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.